Diagnostic value of serum preablative TSH-stimulated thyroglobulin (Tg), Tg/24h 131I neck uptake (RAIU) ratio, and Tg/(RAIUxTSH) ratio in patients with differentiated thyroid carcinoma (DTC)

被引：0
|
作者：
Salvatori, M. [1 ]
Mazza, R. [1 ]
Castaldi, P. [1 ]
Festa, A. [1 ]
Maussier, M. L. [1 ]
Perotti, G. [1 ]
Giordano, A. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Inst Nucl Med, I-00168 Rome, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 25 条
  • [1] The influences of TSH stimulation level, stimulated Tg level and Tg/TSH ratio on the prognosis of 131I treatment in DTC patients
    Zheng, W.
    Rui, Z.
    Wang, X.
    Li, N.
    Meng, Z.
    Tan, J.
    Jia, Q.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S703 - S703
  • [2] The Influences of TSH Stimulation Level, Stimulated Tg Level and Tg/TSH Ratio on the Therapeutic Effect of 131I Treatment in DTC Patients
    Zheng, Wei
    Rui, Zhongying
    Wang, Xuan
    Li, Ning
    Tan, Jian
    Liu, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [3] Stimulated thyroglobulin ( TG) prior to [131I] therapy (RAIT) in patients with differentiated thyroid cancer (DTC) as a predictive factor of recurrence
    Nunez-Munoz, R.
    Ortega, Y. Carreres
    Sarmiento, M. A. Astudillo
    Jorge, R. Valverde
    Fuentes, A. Pena
    Subirats, J. Genolla
    Sandi, J. Santamaria
    Molinuevo, M. Badiola
    Ortiz de Zarate, E. Rodeno
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S586 - S586
  • [4] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [5] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [6] Clinical value of TSH-stimulated thyroglobulin in evaluation of metastasis from differentiated thyroid carcinoma after 131I treatment
    李夏黎
    [J]. China Medical Abstracts (Internal Medicine), 2017, 34 (02) : 67 - 68
  • [7] Editorial:: Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic 131I scanning
    Wartofsky, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1486 - 1489
  • [8] Is TSH-stimulated Tg useful in the short-term follow-up of low-risk patients with differentiated thyroid carcinoma (DTC)?
    Leccisotti, L.
    Rota, C. A.
    Perotti, G.
    Cirillo, F.
    Maussier, M. L.
    Rufini, V.
    Pontecorvi, A.
    Salvatori, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S197 - S197
  • [9] Comparison of recombinant TSH-stimulated serum thyroglobulin (Tg) test, I-131 SPECT/CT, and FDG PET/CT in anti-Tg antibodies (TgAb) positive thyroid cancer
    Nakada, Kunihiro
    Beniko, Mutsuo
    Mashio, Yasuo
    Noriyasu, Kazunori
    Sakuma, Ichiro
    Sakurai, Masayuki
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [10] Serum Thyroglobulin (Tg) measurements before I-131 treatment, under rhTSH preparation, as a prognostic indicator in patients with Differentiated Thyroid Carcinoma (DTC).
    Koutsikos, J.
    Xirafi, I.
    Velidaki, A.
    Tourkohoriti, H.
    Misichronis, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S382 - S383
123